LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | R406 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3747 | 3970 | 0.9437 | 0.9152 |
BT-20 | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 2996 | 3970 | 0.7546 | 0.6303 |
BT-20 | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3831 | 3970 | 0.9649 | 0.9472 |
BT-20 | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 1334 | 1009 | 3970 | 0.2543 | -0.1233 |
BT-20 | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 1334 | 991 | 3970 | 0.2496 | -0.1304 |
BT-20 | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 1606 | 3970 | 0.4046 | 0.1032 |
BT-20 | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 2282 | 3970 | 0.5747 | 0.3594 |
BT-20 | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3680 | 3970 | 0.9268 | 0.8898 |
BT-20 | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 856 | 3970 | 0.2156 | -0.1816 |
BT-20 | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 3024 | 3970 | 0.7616 | 0.6409 |
BT-20 | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 1334 | 2878 | 3970 | 0.7249 | 0.5857 |
BT-20 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 3267 | 3970 | 0.8229 | 0.7332 |
BT-20 | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3702 | 3970 | 0.9325 | 0.8983 |
BT-20 | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3798 | 3970 | 0.9565 | 0.9345 |
BT-20 | JNK-9L | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3591 | 3970 | 0.9044 | 0.8560 |
BT-20 | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3620 | 3970 | 0.9116 | 0.8669 |
BT-20 | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3896 | 3970 | 0.9812 | 0.9717 |
BT-20 | LDN-193189 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 3952 | 3970 | 0.9953 | 0.9930 |
BT-20 | Linifanib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 4160 | 3970 | 1.0476 | 1.0717 |
BT-20 | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 1334 | 4078 | 3970 | 1.0271 | 1.0409 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP5 | 72 | hr | 1334 | 777 | 3970 | 0.1958 | -0.2114 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP6 | 72 | hr | 1334 | 954 | 3970 | 0.2403 | -0.1444 |
BT-20 | MK2206 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3358 | 3970 | 0.8457 | 0.7676 |
BT-20 | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1334 | 2977 | 3970 | 0.7499 | 0.6232 |
BT-20 | Nilotinib | 0.37 | uM | LJP5 | 72 | hr | 1334 | 4227 | 3970 | 1.0646 | 1.0973 |